Global Editions

CRISPR Gene Editing to Be Tested on People by 2017, Says Editas

by Antonio Regalado

The biotechnology startup Editas Medicine intends to begin tests of a powerful new form of gene repair in humans within two years.

Speaking this week at the EmTech conference in Cambridge, Massachusetts, Editas CEO Katrine Bosley said the company hopes to start a clinical trial in 2017 to treat a rare form of blindness using CRISPR, a groundbreaking gene-editing technology.

Read more on technologyreview.com.

اسے اردو میں پڑھیں

Authors

Related posts

*

Top